1	¿	¿	Fia	-	-	531-532	671_QUEST_clinical_caseMIR	SENT1	-	-
2	Cuál	cuál	PT0CS000	-	-	532-536	671_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	537-539	671_QUEST_clinical_caseMIR	SENT1	-	-
4	los	el	DA0MP0	-	-	540-543	671_QUEST_clinical_caseMIR	SENT1	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	544-554	671_QUEST_clinical_caseMIR	SENT1	-	-
6	se	se	P00CN000	-	-	555-557	671_QUEST_clinical_caseMIR	SENT1	-	-
7	asocia	asociar	VMIP3S0	-	-	558-564	671_QUEST_clinical_caseMIR	SENT1	-	-
8	con	con	SPS00	C0332287	atributo	565-568	671_QUEST_clinical_caseMIR	SENT1	-	-
9	una	una		C0205447_1	calificador_1	569-572	671_QUEST_clinical_caseMIR	SENT1	-	-
10	mayor	mayor	AQ0CS0	C0205164#C1704243#C0549177	calificador	573-578	671_QUEST_clinical_caseMIR	SENT1	-	-
11	reducción	reducción	NCFS000	C0333668	anomalía_morfológica	579-588	671_QUEST_clinical_caseMIR	SENT1	-	-
12	del	del	SP+DA	-	-	589-592	671_QUEST_clinical_caseMIR	SENT1	-	-
13	riesgo	riesgo	NCMS000	C1277291_1	escala_de_evaluación_1	593-599	671_QUEST_clinical_caseMIR	SENT1	-	-
14	de	de	SPS00	C1277291_2	escala_de_evaluación_2	600-602	671_QUEST_clinical_caseMIR	SENT1	-	-
15	ACV	acv	NC00YL0	C1277291_3	escala_de_evaluación_3	603-606	671_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
16	?	?	Fit	-	-	606-607	671_QUEST_clinical_caseMIR	SENT1	-	-
17	:	:	Fd	-	-	607-608	671_QUEST_clinical_caseMIR	SENT1	-	-
18	Un	Un		C0205447_1	calificador_1	0-2	671_QUEST_clinical_caseMIR	SENT1	-	-
19	hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	3-9	671_QUEST_clinical_caseMIR	SENT1	-	-
20	de	de	SPS00	C0332285	atributo	10-12	671_QUEST_clinical_caseMIR	SENT1	-	-
21	46	46		-	-	13-15	671_QUEST_clinical_caseMIR	SENT1	-	-
22	años	año	NCMP000	C0439234	calificador	16-20	671_QUEST_clinical_caseMIR	SENT1	-	-
23	con	con	SPS00	C0332287	atributo	21-24	671_QUEST_clinical_caseMIR	SENT1	-	-
24	trastorno	trastorno	NCMS000	C0005586_1	trastorno_1	25-34	671_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
25	bipolar	bipolar	NC00SC0	C0005586_2	trastorno_2	35-42	671_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
26	es	ser	VSIP3S0	-	-	43-45	671_QUEST_clinical_caseMIR	SENT1	-	-
27	llevado	llevar	VMP00SM	-	-	46-53	671_QUEST_clinical_caseMIR	SENT1	-	-
28	a	a	SPS00	-	-	54-55	671_QUEST_clinical_caseMIR	SENT1	-	-
29	urgencias	urgencia	NCFP000	C0439609	calificador	56-65	671_QUEST_clinical_caseMIR	SENT1	-	-
30	tras	tras	SPS00	-	-	66-70	671_QUEST_clinical_caseMIR	SENT1	-	-
31	una	una		C0205447_1	calificador_1	71-74	671_QUEST_clinical_caseMIR	SENT1	-	-
32	sobreingesta	sobreingesta	NCFS000	-	-	75-87	671_QUEST_clinical_caseMIR	SENT1	-	-
33	de	de	SPS00	C0332285	atributo	88-90	671_QUEST_clinical_caseMIR	SENT1	-	-
34	carbonato	carbonato	NCMS000	C0085217_1	sustancia_1	91-100	671_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
35	de	de	SPS00	C0085217_2	sustancia_2	101-103	671_QUEST_clinical_caseMIR	SENT1	-	-
36	litio	litio	NCMS000	C0085217_3	sustancia_3	104-109	671_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
37	.	.	Fp	-	-	109-110	671_QUEST_clinical_caseMIR	SENT1	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	111-113	671_QUEST_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	114-116	671_QUEST_clinical_caseMIR	SENT2	-	-
3	exploración	exploración	NCFS000	C1280903	procedimiento	117-128	671_QUEST_clinical_caseMIR	SENT2	-	-
4	destaca	destacar	VMIP3S0	-	-	129-136	671_QUEST_clinical_caseMIR	SENT2	-	-
5	temblor	temblor	NCMS000	C0040822#C1527384_1	hallazgo_1	137-144	671_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
6	intenso	intenso	AQ0MS0	C0205178	calificador	145-152	671_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
7	,	,	Fc	-	-	152-153	671_QUEST_clinical_caseMIR	SENT2	-	-
8	ataxia	ataxia	NCFS000	C0004134	hallazgo	154-160	671_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
9	,	,	Fc	-	-	160-161	671_QUEST_clinical_caseMIR	SENT2	-	-
10	disartria	disartria	NCFS000	C0013362	hallazgo	162-171	671_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
11	,	,	Fc	-	-	171-172	671_QUEST_clinical_caseMIR	SENT2	-	-
12	mioclonías	mioclonías	NC00KE0	-	-	173-183	671_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
13	y	y	CC	C1706368	calificador	184-185	671_QUEST_clinical_caseMIR	SENT2	-	-
14	fasciculaciones	fasciculaciones	NCFP000	-	-	186-201	671_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
15	.	.	Fp	-	-	201-202	671_QUEST_clinical_caseMIR	SENT2	-	-

1	La	el	DA0FS0	-	-	203-205	671_QUEST_clinical_caseMIR	SENT3	-	-
2	litemia	litemia	NCFS000	-	-	206-213	671_QUEST_clinical_caseMIR	SENT3	-	-
3	es	ser	VSIP3S0	-	-	214-216	671_QUEST_clinical_caseMIR	SENT3	-	-
4	de	de	SPS00	C0332285	atributo	217-219	671_QUEST_clinical_caseMIR	SENT3	-	-
5	4,1	4,1		-	-	220-223	671_QUEST_clinical_caseMIR	SENT3	-	-
6	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	224-227	671_QUEST_clinical_caseMIR	SENT3	-	-
7	/	/	Fh	-	-	227-228	671_QUEST_clinical_caseMIR	SENT3	-	-
8	L	l	NCFS000	-	-	228-229	671_QUEST_clinical_caseMIR	SENT3	-	-
9	(	(	Fpa	-	-	230-231	671_QUEST_clinical_caseMIR	SENT3	-	-
10	toxicidad	toxicidad	NCFS000	C0600688	-	231-240	671_QUEST_clinical_caseMIR	SENT3	-	-
11	>	>	Fz	-	-	241-242	671_QUEST_clinical_caseMIR	SENT3	-	-
12	1,6	1,6		-	-	243-246	671_QUEST_clinical_caseMIR	SENT3	-	-
13	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	247-250	671_QUEST_clinical_caseMIR	SENT3	-	-
14	/	/	Fh	-	-	250-251	671_QUEST_clinical_caseMIR	SENT3	-	-
15	L	l	NCFS000	-	-	251-252	671_QUEST_clinical_caseMIR	SENT3	-	-
16	)	)	Fpt	-	-	252-253	671_QUEST_clinical_caseMIR	SENT3	-	-
17	.	.	Fp	-	-	253-254	671_QUEST_clinical_caseMIR	SENT3	-	-

